Daily Bulletins

At the end of every day of the conference (3-5 November) jargon-free bulletins will be posted here, giving the highlights of the clinical and scientific sessions of the meeting.

DAY 1: International Symposium on MND comes home to England

Science Minister Lord Drayson opens the 19th International Symposium on ALS/MND.

DAY 1: Biologists beware: a cautionary tale from a medicinal chemist!

The importance of consulting medicinal chemists as early as possible when MND researchers begin the journey of taking their promising chemicals from the laboratory to the clinic.

DAY 1: New clues on how TDP43 causes motor neurones to die

Researchers have shown that there is a causal link between TDP43 and MND. The search is now on to find out how the two are linked together.

DAY 2: Full and frank discussions on the use of a mouse model of MND

A panel of experts concluded that although there are many flaws with the 'SOD1' mouse model of MND/ALS, we should learn to work with this mouse and improve it.

DAY 2: Beyond Guam: New aspects of the cyanobacteria/BMAA hypothesis

An entire session at the symposium was devoted to the toxin BMAA, produced by cyanbacteria, an ancient bacteria found throughout the world in a wide range of environments.

DAY 2: Using cannabis for the treatment of cramps in MND

The findings from a randomized placebo controlled trial to determine the safety and effectiveness of using THC (taken from the cannabis plant) for the treatment of cramps in people with MND.

DAY 2: The Poster Session explained

Find out just what the Poster Session is!

DAY 3: MND Association grantees present their results at the International Symposium on ALS/MND

Our grantees explain how different models of MND – from mice to fruit flies - can tell us about what causes motor neurones to die on a cellular level.

DAY 3: Stem cells and ALS/MND: Where are we now?

Prof Clive Svendsen explains how stem cells can be used to help further MND research.